7 results  1 of 1 

1 Latent and Active Tuberculosis Infection in Patients with Inflammatory Bowel Disease
Byung Chul Jin, Hee Jin Moon, Sang Wook Kim
Korean J Gastroenterol.2022;80(2):72-76.   Published online 2022 August 25     DOI: http://dx.doi.org/10.4166/kjg.2022.086
      
2 Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation
Brigida Barberio, Edoardo Vincenzo Savarino, Timothy Card, Cristina Canova, Francesco Baldisser, Alessandro Gubbiotti, Davide Massimi, Matteo Ghisa, Fabiana Zingone
Intest Res.2022;20(1):114-123.   Published online 2021 August 4     DOI: http://dx.doi.org/10.5217/ir.2021.00037
      
3 Nomenclature of emerging therapeutics in neurology
Jin-Hong Shin, Young-Eun Park, Dae-Seong Kim
Ann Clin Neurophysiol.2021;23(1):29-34.   Published online 2021 April 29     DOI: http://dx.doi.org/10.14253/acn.2021.23.1.29
      
4 Ustekinumab is effective in biological refractory Crohn’s disease patients–regardless of approval study selection criteria
Sadik Saman, Martin Goetz, Judith Wendler, Nisar P. Malek, Jan Wehkamp, Thomas Klag
Intest Res.2019;17(3):340-348.   Published online 2019 May 31     DOI: http://dx.doi.org/10.5217/ir.2019.00012
      
5 Risk of surgery in patients with stricturing type of Crohn’s disease at the initial diagnosis: a single center experience
Yuji Maehata, Yutaka Nagata, Tomohiko Moriyama, Yuichi Matsuno, Atsushi Hirano, Junji Umeno, Takehiro Torisu, Tatsuya Manabe, Takanari Kitazono, Motohiro Esaki
Intest Res.2019;17(3):357-364.   Published online 2019 February 21     DOI: http://dx.doi.org/10.5217/ir.2018.00107
      
6 Immunotherapy in endometrial cancer: new scenarios on the horizon
Chiara Di Tucci, Carmela Capone, Giulia Galati, Valentina Iacobelli, Michele C Schiavi, Violante Di Donato, Ludovico Muzii, Pierluigi Benedetti Panici
J Gynecol Oncol.2019;30(3):e46.  Published online 2019 January 8     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e46
      
7 Transaminase Changes in Korean Rheumatoid Arthritis Patients with Chronic Hepatitis C after Biologic Therapy
Hyun Mi Kwon, Kichul Shin, Jin Young Moon, Shin-Seok Lee, Won Tae Chung, Jisoo Lee, Sang-Heon Lee, Seong-Wook Kang, Chang Hee Suh, Seung-Jae Hong, Ran Song, Jung-Yoon Choe, Yeong Wook Song
J Rheum Dis.2018;25(2):108-115.   Published online 2018 April 30     DOI: http://dx.doi.org/10.4078/jrd.2018.25.2.108
   

 1 of 1